
Abbott Laboratories ABT
$ 100.9
0.21%
Annual report 2025
added 02-20-2026
Abbott Laboratories Interest Expense 2011-2026 | ABT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 548 M | 376 M | 479 M | 321 M | 533 M | 546 M | 670 M | 826 M | 904 M | 431 M | 163 M | 150 M | 145 M | 320 M | 359 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 904 M | 145 M | 451 M |
Quarterly Interest Expense Abbott Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 137 M | 127 M | 121 M | -10 M | 111 M | 83 M | 176 M | 153 M | - | 141 M | 132 M | 131 M | - | 133 M | 134 M | 135 M | - | 137 M | 134 M | 139 M | - | 167 M | 168 M | 171 M | - | 203 M | 210 M | 227 M | - | 218 M | 214 M | 226 M | - | 117 M | 103 M | 58 M | - | 41 M | 44 M | 37 M | - | 35 M | 36 M | 36 M | - | 37 M | 40 M | 41 M | - | 152 M | 83.3 M | 82.1 M | - | 124 M | 134 M | 146 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 227 M | -10 M | 120 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 185.57 | 2.71 % | $ 13.9 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
AxoGen
AXGN
|
167 K | $ 34.13 | 1.97 % | $ 1.57 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.71 | 3.17 % | $ 1.72 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 291.68 | 1.22 % | $ 8.23 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.22 | -3.23 % | $ 121 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.91 | 2.2 % | $ 5.95 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 64.04 | 1.36 % | $ 94.8 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
LENSAR
LNSR
|
636 K | $ 6.03 | 1.86 % | $ 72.1 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 10.29 | 2.8 % | $ 291 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
-668 K | $ 0.77 | 5.27 % | $ 32.2 M | ||
|
Electromed
ELMD
|
78 K | $ 25.41 | 1.84 % | $ 215 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.36 | -1.4 % | $ 169 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.85 | -3.06 % | $ 7.9 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 95.44 | 2.65 % | $ 12.9 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.97 | -2.96 % | $ 1.2 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.39 | 2.57 % | $ 929 M | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 115.53 | 1.91 % | $ 3.93 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Tandem Diabetes Care
TNDM
|
-13 M | $ 20.79 | 3.45 % | $ 1.41 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.7 | 4.42 % | $ 415 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.74 | 2.78 % | $ 385 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 55.81 | 1.62 % | $ 1.64 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 39.41 | 2.47 % | $ 1.22 B |